Production (Stage)
Adverum Biotechnologies, Inc.
ADVM
$2.21
-$0.02-0.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | 19.31% | 17.89% | |||
| Gross Profit | -19.31% | -23.95% | |||
| SG&A Expenses | -48.92% | 289.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.50% | 105.87% | |||
| Operating Income | 22.50% | -112.92% | |||
| Income Before Tax | 22.32% | -123.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.32% | -123.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.32% | -123.08% | |||
| EBIT | 22.50% | -112.92% | |||
| EBITDA | 22.59% | -116.75% | |||
| EPS Basic | 22.47% | -122.83% | |||
| Normalized Basic EPS | 22.47% | -122.83% | |||
| EPS Diluted | 22.47% | -122.83% | |||
| Normalized Diluted EPS | 22.47% | -122.83% | |||
| Average Basic Shares Outstanding | 0.19% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||